13 11, 2020 Join us at Medica Virtual from 16 to 19 November Join us at Medica Virtual from 16 to 19 November Nachrichten, Veranstaltungen Join us at Medica Virtual from 16 to 19 November Diatech Pharmacogenetics2020-11-19T14:39:02+01:00 Mehr erfahren
12 11, 2020 A successful validation of EasyPGX PIK3CA testing Diatech Pharmacogenetics2020-11-19T14:40:39+01:00 Mehr erfahren
4 11, 2020 NGS: made it Easy with Myriapod Dry! Diatech Pharmacogenetics2020-11-04T16:29:45+01:00 Mehr erfahren
4 11, 2020 EasyPGX ready KRAS together with KRAS G12C inhibitors: one more weapon in the fight against cancer! Diatech Pharmacogenetics2020-11-05T11:15:24+01:00 Mehr erfahren
14 10, 2020 Federica Bertolini et. al., Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance Diatech Pharmacogenetics2020-11-03T11:53:39+01:00 Mehr erfahren
1 10, 2020 Test auf DPD-Mangel – neue Leistung im EBM Diatech Pharmacogenetics2020-11-04T10:17:43+01:00 Mehr erfahren
28 09, 2020 Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved Diatech Pharmacogenetics2020-09-28T18:43:55+02:00 Mehr erfahren
28 09, 2020 Francesco Cortiula et. al., A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients Diatech Pharmacogenetics2020-11-03T11:56:51+01:00 Mehr erfahren
9 09, 2020 Magda Zanelli et. al., Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study Diatech Pharmacogenetics2020-11-03T12:02:43+01:00 Mehr erfahren
4 09, 2020 Pierina Navarria et. al., Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series Diatech Pharmacogenetics2020-09-04T13:57:59+02:00 Mehr erfahren
